{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:08:46Z","timestamp":1788898126630,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epidemiological studies regarding the correlation between anti-M\u00fcllerian hormone (AMH) and insulin resistance (IR) in polycystic ovarian syndrome (PCOS) remain inconsistent. The primary aim of this study was to determine the correlations between AMH and IR in patients with PCOS and to explore the selected factors that influence the correlations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted systemic searches of online databases (PubMed, Science Direct, Taylor and Francis, Scopus, and ProQuest) from inception to December 20, 2023 and manual searches of the associated bibliographies to identify relevant studies. We then performed subgroup and sensitivity analyses to explore the sources of heterogeneity, followed by a publication bias risk assessment of the included studies using the Joanna Briggs Institute critical appraisal tool. We used a random-effects model to estimate the pooled correlations between AMH and the homeostatic model assessment for insulin resistance (HOMA-IR) in patients with polycystic ovarian syndrome (PCOS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 4835 articles identified, 22 eligible relevant studies from three regions were included and identified as low risk of bias. The random-effects pooled correlation estimate was 0.089 (95% confidence interval [CI]: \u22120.040, 0.215), with substantial heterogeneity (I<jats:sup>2<\/jats:sup>\u2009=\u200987%; \u03c4<jats:sup>2<\/jats:sup>\u2009=\u20090.0475, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). Subgroup analyses showed that the study region did not influence the correlation estimates, and sensitivity analysis showed no significant alteration in the pooled correlation estimate or 95% CI values. No publication bias was observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There was a weak, statistically insignificant correlation between AMH and HOMA-IR in patients with PCOS. The correlation estimates did not vary according to the study participants\u2019 regions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01436-x","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:02:17Z","timestamp":1716022937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Mohd Zakwan","family":"Md Muslim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniza","family":"Mohammed Jelani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorazliyana","family":"Shafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib Majdi","family":"Yaacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Azlin Azraini","family":"Che Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanim Afzan","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"issue":"4","key":"1436_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261.","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"1436_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mefs.2010.10.002","volume":"16","author":"GN Allahbadia","year":"2011","unstructured":"Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil Soc J. 2011;16(1):19\u201337.","journal-title":"Middle East Fertil Soc J"},{"issue":"1","key":"1436_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1436_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"key":"1436_CR5","doi-asserted-by":"crossref","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. International journal of reproductive medicine. 2014;2014.","DOI":"10.1155\/2014\/719050"},{"key":"1436_CR6","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"13, Azziz R, Carmina E, Chen Z, Dunaif A, Laven J, Legro RS, et al. Polycystic ovary syndrome. Nat Reviews Disease Primers. 2016;2:16057.","journal-title":"Nat Reviews Disease Primers"},{"key":"1436_CR7","doi-asserted-by":"crossref","unstructured":"Rzeszowska M, Leszcz A, Putowski L, Ha\u0142abi\u015b M, Tkaczuk-W\u0142ach J, Kotarski J et al. Anti-M\u00fcllerian hormone: structure, properties and appliance. Ginekologia Polska. 2016;87(9).","DOI":"10.5603\/GP.2016.0064"},{"issue":"11","key":"1436_CR8","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LM Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LM, Visser JA. Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105(11):3361\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"1436_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00404-014-3317-2","volume":"290","author":"A K\u00f6ninger","year":"2014","unstructured":"K\u00f6ninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, et al. Anti-mullerian hormone: an indicator for the severity of polycystic ovarian syndrome. Arch Gynecol Obstet. 2014;290:1023\u201330.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"1436_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","volume":"30","author":"H Teede","year":"2019","unstructured":"Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, et al. Anti-M\u00fcllerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metabolism. 2019;30(7):467\u201378.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"1","key":"1436_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016;33(1):15\u201328.","journal-title":"Reprod Biomed Online"},{"key":"1436_CR12","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int Surg J. 2021;88:105906.","journal-title":"Int Surg J"},{"key":"1436_CR13","first-page":"217","volume":"5","author":"S Moola","year":"2017","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: systematic reviews of etiology and risk. Joanna Briggs institute reviewer\u2019s manual. Joanna Briggs Inst. 2017;5:217\u201369.","journal-title":"Joanna Briggs Inst"},{"issue":"1","key":"1436_CR14","doi-asserted-by":"publisher","first-page":"e0263139","DOI":"10.1371\/journal.pone.0263139","volume":"17","author":"S Akhtar","year":"2022","unstructured":"Akhtar S, Nasir JA, Ali A, Asghar M, Majeed R, Sarwar A. Prevalence of type-2 diabetes and prediabetes in Malaysia: a systematic review and meta-analysis. PLoS ONE. 2022;17(1):e0263139.","journal-title":"PLoS ONE"},{"key":"1436_CR15","unstructured":"Zhang F, Du J, Wang B, Wen H, Jia X, Chen H et al. Dynamics of hormonal profile and anti-mullerian hormone during spontaneous ovulation in PCOS women with oligomenorrhea. Biomed Res. 2017;28(6)."},{"key":"1436_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Rothstein hr. Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges LV, Higgins JP. Rothstein hr. Introduction to meta-analysis. West Sussex, England: Wiley & Sons Ltd; 2009."},{"key":"1436_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2022. https:\/\/www.r-project.org\/. Accessed November 23, 2022."},{"issue":"7414","key":"1436_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"2","key":"1436_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I\u00b2 index? Psychol Methods. 2006;11(2):193.","journal-title":"Psychol Methods"},{"key":"1436_CR20","doi-asserted-by":"crossref","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert D. Doing meta-analysis with R: a hands-on guide. Volume 14. Chapman and Hall\/CRC; 2021 Sep.","DOI":"10.1201\/9781003107347"},{"issue":"11","key":"1436_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"1436_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-109","volume":"14","author":"M Gjerdevik","year":"2014","unstructured":"Gjerdevik M, Heuch I. Improving the error rates of the Begg and Mazumdar test for publication bias in fixed effects meta-analysis. BMC Med Res Methodol. 2014;14(1):1\u20136.","journal-title":"BMC Med Res Methodol"},{"key":"1436_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2015.06.022","volume":"192","author":"SH Shen","year":"2015","unstructured":"Shen SH, Shen SY, Liou TH, Hsu MI, Chang YC, Cheng CY, et al. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;192:66\u201371.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1436_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.fertnstert.2016.10.009","volume":"107","author":"RA Feldman","year":"2017","unstructured":"Feldman RA, O\u2019Neill K, Butts SF, Dokras A. Antim\u00fcllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome. Fertil Steril. 2017;107(1):276\u201381.","journal-title":"Fertil Steril"},{"issue":"4","key":"1436_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","volume":"82","author":"A La Marca","year":"2004","unstructured":"La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. M\u00fcllerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82(4):970\u20132.","journal-title":"Fertil Steril"},{"issue":"10","key":"1436_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3109\/09513590.2015.1056143","volume":"31","author":"S Chun","year":"2015","unstructured":"Chun S. 1-h postprandial glucose level is related to the serum anti-M\u00fcllerian hormone level in women with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(10):815\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"1436_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00404-013-2833-9","volume":"288","author":"GS Caglar","year":"2013","unstructured":"Caglar GS, Kahyaoglu I, Pabuccu R, Demirtas S, Seker R. Anti-mullerian hormone and insulin resistance in classic phenotype lean PCOS. Arch Gynecol Obstet. 2013;288:905\u201310.","journal-title":"Arch Gynecol Obstet"},{"key":"1436_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.03.007","volume":"224","author":"S Sahmay","year":"2018","unstructured":"Sahmay S, Mathyk BA, Sofiyeva N, Atakul N, Azemi A, Erel T. Serum AMH levels and insulin resistance in women with PCOS. Eur J Obstet Gynecol Reprod Biol. 2018;224:159\u201364.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"1436_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1080\/09513590.2016.1193140","volume":"32","author":"A Tokmak","year":"2016","unstructured":"Tokmak A, Kokanali D, Timur H, Kuntay Kokanali M, Yilmaz N. Association between anti-mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(11):926\u201330.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1436_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","volume":"158","author":"P Ska\u0142ba","year":"2011","unstructured":"Ska\u0142ba P, Cygal A, Madej P, D\u0105bkowska-Hu\u0107 A, Sikora J, Martirosian G, et al. Is the plasma anti-M\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod. 2011;158(2):254\u20139.","journal-title":"Eur J Obstet Gynecol Reprod"},{"issue":"2","key":"1436_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/ijem.IJEM_305_19","volume":"24","author":"TJ Jun","year":"2020","unstructured":"Jun TJ, Jelani AM, Omar J, Rahim RA, Yaacob NM. Serum anti-m\u00fcllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin. Indian J Endocrinol Metab. 2020;24(2):191.","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"1436_CR32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3109\/09513590.2014.943719","volume":"30","author":"X Tian","year":"2014","unstructured":"Tian X, Ruan X, Mueck AO, Wallwiener D, Wang J, Liu S, et al. Serum anti-M\u00fcllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Gynecol Endocrinol. 2014;30(11):836\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1436_CR33","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/humrep\/den015","volume":"23","author":"MJ Chen","year":"2008","unstructured":"Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN. The relationship between anti-M\u00fcllerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod. 2008;23(4):952\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"1436_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3207-y","volume":"11","author":"B Wiweko","year":"2018","unstructured":"Wiweko B, Indra I, Susanto C, Natadisastra M, Hestiantoro A. The correlation between serum AMH and HOMA-IR among PCOS phenotypes. BMC Res Notes. 2018;11(1):1\u20136.","journal-title":"BMC Res Notes"},{"issue":"2","key":"1436_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/09513590.2018.1505847","volume":"35","author":"B \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk B, G\u00fcrb\u00fcz AS, Durak ZE, \u00d6zt\u00fcrk HS. Dipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(2):138\u201341.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1436_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3906\/sag-1808-52","volume":"49","author":"AY \u015eahin","year":"2019","unstructured":"\u015eahin AY, Ba\u015f F, YET\u0130M \u00c7, U\u00e7ar A, Poyrazo\u011flu \u015e, Bundak R, et al. Determination of insulin resistance and its relationship with hyperandrogenemia, anti-M\u00fcllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome. Turkish J Med Sci. 2019;49(4):1117\u201325.","journal-title":"Turkish J Med Sci"},{"key":"1436_CR37","doi-asserted-by":"crossref","unstructured":"Gupta M, Yadav R, Mahey R, Agrawal A, Upadhyay A, Malhotra N, Bhatla N. Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes\u2013a cross-sectional study. Gynecol Endocrinol. 2019 May 12.","DOI":"10.1080\/09513590.2019.1613640"},{"key":"1436_CR38","doi-asserted-by":"crossref","unstructured":"Sharma M, Singh HV, Geethanjali G, Jain PK, Ranjan R. Correlation of anti mullerian hormone with Homeostatic Model Assessment-Insulin Resistance in polycystic ovarian syndrome and normally ovulating women. J Clin Diagn Res. 2019;13(11).","DOI":"10.7860\/JCDR\/2019\/40938.13289"},{"issue":"2","key":"1436_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19396368.2020.1860155","volume":"67","author":"H Fu","year":"2021","unstructured":"Fu H, Lin Y, Deng X, Wu L. Correlation between anti-mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. Syst Biol Reprod Med. 2021;67(2):112\u201320.","journal-title":"Syst Biol Reprod Med"},{"issue":"7","key":"1436_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/09513590.2018.1559807","volume":"35","author":"H Sova","year":"2019","unstructured":"Sova H, Unkila-Kallio L, Tiitinen A, Hippel\u00e4inen M, Perheentupa A, Tinkanen H, et al. Hormone profiling, including anti-M\u00fcllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecol Endocrinol. 2019;35(7):595\u2013600.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1436_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","volume":"59","author":"HY Woo","year":"2012","unstructured":"Woo HY, Kim KH, Rhee EJ, Park H, Lee MK. Differences of the association of anti-M\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J. 2012;59(9):781\u201390.","journal-title":"Endocr J"},{"issue":"8","key":"1436_CR42","doi-asserted-by":"publisher","first-page":"e0203129","DOI":"10.1371\/journal.pone.0203129","volume":"13","author":"CY Yue","year":"2018","unstructured":"Yue CY, Lu LK, Li M, Zhang QL, Ying CM. Threshold value of anti-mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS ONE. 2018;13(8):e0203129.","journal-title":"PLoS ONE"},{"key":"1436_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/IJWH.S393594","volume":"15","author":"D Han Zhao","year":"2023","unstructured":"Han Zhao D, Zhou C, Liu L, Zhang. The relationship between insulin resistance and obesity and serum anti-mullerian hormone level in Chinese women with polycystic ovary syndrome: a retrospective, single-Center Cohort Study. Int J Womens Health. 2023;15:151\u201366. PMID: 36778752; PMCID: PMC9911904.","journal-title":"Int J Womens Health"},{"key":"1436_CR44","doi-asserted-by":"publisher","first-page":"818912","DOI":"10.1155\/2013\/818912","volume":"2013","author":"R Tal","year":"2013","unstructured":"Tal R, Seifer DB. Potential mechanisms for racial and ethnic differences in antim\u00fcllerian hormone and ovarian reserve. Int J Endocrinol. 2013;2013:818912. https:\/\/doi.org\/10.1155\/2013\/818912. Epub 2013 Nov 21. PMID: 24348557; PMCID: PMC3857838.","journal-title":"Int J Endocrinol"},{"key":"1436_CR45","doi-asserted-by":"publisher","first-page":"593216","DOI":"10.3389\/fendo.2020.593216","volume":"11","author":"AM Kotlyar","year":"2021","unstructured":"Kotlyar AM, Seifer DB. Ethnicity\/race and age-specific variations of serum AMH in women\u2014a review. Front Endocrinol. 2021;11:593216.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1436_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.rbmo.2022.06.023","volume":"45","author":"PS Gromski","year":"2022","unstructured":"Gromski PS, Patil RS, Chougule SM, Bhomkar DA, Jirge PR, Nelson SM. Ethnic discordance in serum anti-M\u00fcllerian hormone in European and Indian healthy women and Indian infertile women. Reprod Biomed Online. 2022;45(5):979\u201386.","journal-title":"Reprod Biomed Online"},{"key":"1436_CR47","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K et al. 2020. https:\/\/synthesismanual.jbi.global. Borzan V, Lerchbaum E, Missbrenner C, Heijboer AC, Goschnik M, Trummer C,. Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: a comparison between PCOS phenotypes and beyond. Journal of Clinical Medicine. 2021;10(4):829.","DOI":"10.3390\/jcm10040829"},{"key":"1436_CR48","doi-asserted-by":"crossref","unstructured":"Borzan V, Lerchbaum E, Missbrenner C, Heijboer AC, Goschnik M, Trummer C,. Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: a comparison between PCOS phenotypes and beyond. Journal of Clinical Medicine. 2021;10(4):829.","DOI":"10.3390\/jcm10040829"},{"issue":"4","key":"1436_CR49","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2013;98(4):E628\u201337.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1436_CR50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1436_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-47","volume":"13","author":"P Gayoso-Diz","year":"2013","unstructured":"Gayoso-Diz P, Otero-Gonz\u00e1lez A, Rodriguez-Alvarez MX, Gude F, Garc\u00eda F, De Francisco A, Quintela AG. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13(1):1\u20130.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"1436_CR52","doi-asserted-by":"publisher","first-page":"e1919325","DOI":"10.1001\/jamanetworkopen.2019.19325","volume":"3","author":"PB Imrey","year":"2020","unstructured":"Imrey PB. Limitations of Meta-analyses o of studies with high heterogeneity. JAMA Netw Open. 2020;3(1):e1919325. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.19325.","journal-title":"JAMA Netw Open"},{"key":"1436_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1590\/2176-9451.19.4.027-029.ebo","volume":"19","author":"J Faber","year":"2014","unstructured":"Faber J, Fonseca LM. How sample size influences research outcomes. Dent Press J Orthod. 2014;19:27\u20139.","journal-title":"Dent Press J Orthod"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01436-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T10:02:47Z","timestamp":1716026567000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1436"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01436-x","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}